Fifth Third Bancorp (NASDAQ: FITB) has announced a quarterly dividend of $0.40 per share, totaling $1.6 annualized, representing a 3% yield. The dividend is payable on July 15, 2026, to stockholders of record by June 30, 2026, with an ex-dividend date of June 29, 2026. This declaration was made on June 11, 2026, according to the article.

Norwegian Cruise Line Holdings reported Q1 2026 results showing 10% revenue growth and expanded operating margins to 11%, alongside a cut in full-year net yield guidance due to market pressures and internal execution issues. Despite revenue challenges, the company is demonstrating cost control through SG&A savings, with a potential for $30 stock valuation by December 2030 if revenue recovery accelerates in 2027. The article highlights NCLH's operating margin gap compared to Royal Caribbean and suggests that announced cost reductions are crucial for closing this gap.

This article provides details on Kura Oncology, Inc. (NASDAQ: KURA), focusing on its number of shareholders. It lists various financial data sources and tools available on the TradingView platform for analyzing the company's performance. The article does not provide the actual number of shareholders but rather the framework within which such data could be accessed.

LivaNova PLC has announced the election of Jette Nygaard-Andersen to its Board of Directors, following the annual general meeting on June 10. Ms. Nygaard-Andersen brings extensive experience in medtech governance, CEO leadership, and digital innovation, currently serving as Chair of Coloplast A/S. Concurrently, Dr. Sharon O’Kane stepped down from the Board after over a decade of service, with Brooke Story succeeding her as Chair of the Nominating and Corporate Governance Committee.

This article summarizes recent activities and news from prominent hedge funds and insider trading events involving figures like Ken Griffin, Eli Casdin, Catherine D. Wood, and Ray Dalio. Key highlights include Ken Griffin's increased investment in Miami, Eli Casdin's accumulation of GeneDx shares, Cathie Wood selling Robinhood stock and investing in an AI stock, and Ray Dalio's stock market verdict. Additionally, it covers insider selling in Liquidia Corp (LQDA) and Ramaco Resources Inc (METC) and mentions several other significant hedge fund developments.

This article compares Algonquin Power & Utilities (AQN) and CenterPoint Energy (CNP) to determine which is a better investment in 2026, focusing on their financial health, operations, and valuations. While Algonquin is in a turnaround phase, CenterPoint Energy is highlighted for its growth potential, particularly in the rapidly expanding Houston electricity market. The author ultimately recommends CenterPoint Energy due to its strong growth story and capital investment plans.

Southern California Edison (SCE) will host a community meeting on June 30 in Pasadena to provide updates on its Wildfire Recovery Compensation Program following the Eaton Fire. The program has offered over $675 million to community members, and a recent survey indicates 82% favorable feedback from participants. The meeting aims to connect community members with recovery resources and feature a panel discussion with program participants.

Accounting firm Crowe has agreed to sell a majority stake to KKR and co-investors in a deal valued at nearly $3 billion. This move reflects a growing trend of private-equity investments in the accounting industry, as firms seek capital to fund AI adoption and expansion efforts. Crowe partners will retain a minority stake in the Chicago-based firm.

Citigroup is launching a new venture using tokenized depositary receipts on a blockchain to allow wealthy and institutional clients to invest in private companies like SpaceX and Anthropic directly alongside their public equity holdings. This initiative aims to provide a cleaner, more transparent alternative to traditional special-purpose vehicles, initially targeting foreign investors with plans for future U.S. access. Citi's stock performance is analyzed, noting its recent gains and upcoming earnings report as a potential catalyst.

Humana is selling its stake in Gentiva for $900 million. This sale is linked to Humana's 2021 acquisition strategy and comes as the insurer faces increased medical costs and declining Medicare Advantage membership.